I usually devote this column to the 340B program or other prescription drug pricing issues but this month will be different. Late Friday, I got the news that David Gergen, my first boss out of college and an important mentor to me and countless others, passed away.

David was a senior adviser to four U.S. presidents and understood the importance of bipartisanship. I was very lucky to work for him at U.S. News & World Report for close to four years and to call him and his wife, Anne, longtime friends. Read More >